AB Private Lending Fund (AB-LEND) is a public, non-traded, perpetually offered business development company that provides investors access to US direct lending—a sizable asset class that we believe offers attractive risk-adjusted return potential. AB Private Credit Investors (AB-PCI), AB’s direct lending platform established in 2014, advises AB-LEND in partnership with AB’s High Yield team as sub-adviser, combining two long-standing AB teams to deliver AB-LEND in a dynamic credit market.
*As of September 30, 2024
AB-LEND exhibits the broad strength and expertise of AllianceBernstein. The collaborative approach between AB-PCI and AB High Yield benefits investors in a solution positioned to provide strong income in a dynamic leveraged credit market.
Brent Humphries—AB-PCI | President and Founding Member
| Filings | Description | Date Filed |
|---|---|---|
| SC TO-I | Tender Offer Statement | March 27, 2026 |
| 8-K | Current report filings | March 19, 2026 |
| 8-K | Current report filings | February 20, 2026 |
| Schedule 13G/A | Statement of Beneficial Ownership by Certain Investors, Amendment | February 17, 2026 |
| Schedule 13G/A | Statement of Beneficial Ownership by Certain Investors, Amendment | February 17, 2026 |
| 8-K | Current report filings | February 9, 2026 |
| SC TO-I/A | Amendment to Tender offer statement by Issuer | February 5, 2026 |
| 8-K | Current report filings | January 22, 2026 |
| 8-K | Current report filings | December 30, 2025 |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | December 29, 2025 |
| SC TO-I | Tender offer statement | December 29, 2025 |
| 8-K | Current report filings | November 21, 2025 |
| Schedule 13G | Statement of Beneficial Ownership by Certain Investors | November 14, 2025 |
| Schedule 13G/A | Statement of Beneficial Ownership by Certain Investors, Amendment | November 14, 2025 |
| Form 10-Q | Quarterly Report | November 12, 2025 |
| 40-17G | Fidelity Bond | November 12, 2025 |
| SC TO-I/A | Amendment to Tender Offer Statement by Issuer | November 6, 2025 |
| 8-K | Current report filings | October 20, 2025 |
| 40-APP/A | Co-Investment Relief Request | October 3, 2025 |
| SC TO-I | Tender offer statement | September 26, 2025 |
| 8-K | Current report filings | September 22, 2025 |
| 8-K | Current report filings | September 19, 2025 |
| 8-K | Current report filings | September 19, 2025 |
| 424B3 | Prospectus filed pursuant to Rule 424(b)(3) | September 16, 2025 |
| DEF 14A | Other definitive proxy statements | August 8, 2025 |
| 486BPOS | Post-effective amendment | May 14, 2025 |
| 8-K | Current report filings | March 21, 2025 |
| 10-Q | Quarterly report | November 14, 2024 |
Prospectus filed pursuant to Rule 424(b)(3) |
November 6, 2024 |
|
Prospectus filed pursuant to Rule 424(b)(3) |
August 22, 2024 |
|
Prospectus filed pursuant to Rule 424(b)(3) |
August 8, 2024 |
Access all AB-LEND SEC filings and documents on EDGAR.
| Document | Descriptions |
|---|---|
| Charters | Audit Committee Charter |
| Charters | Nominating and Corporate Governance Charter |
This is neither an offer to sell nor a solicitation of an offer to buy the securities described herein; an offering is made only by prospectus. This information must be preceded or accompanied by a prospectus in order to understand fully all of the implications and risks of the offering. Neither the Securities and Exchange Commission nor any other state securities regulator has approved or disapproved of our securities or determined if our prospectus is truthful or complete. Neither the Attorney General of the State of New York nor any other state securities regulator has approved or disapproved of the securities described herein, determined if the prospectus is truthful or complete or passed on or endorsed the merits of this offering. Any representation to the contrary is a criminal offense.
AllianceBernstein Investments, Inc. is the dealer manager for the AB-LEND offering.
IMPORTANT RISK INFORMATION
An investment in AB-LEND involves a high degree of risk. You should purchase these securities only if you can afford a complete loss of your investment. Investors should review the offering documents, including the description of risk factors contained in the prospectus, prior to making a decision to invest in the securities described herein. The prospectus will include more complete descriptions of the risks described below as well as additional risks relating to, among other things, conflicts of interest and regulatory and tax matters. Any decision to invest in the securities described herein should be made after reviewing such prospectus, conducting such investigations as the investor deems necessary and consulting the investor’s own legal, accounting and tax advisors in order to make an independent determination of the suitability and consequences of an investment in AB-LEND.
Investors should consider the investment objectives, risks, charges and expenses of the Fund/Portfolio carefully before investing. For copies of our prospectus or summary prospectus, which contain this and other information click here. Please read the prospectus and/or summary prospectus carefully before investing.